The genetic polymorphisms of PAI‐1 are linked to lower PAI‐1 plasma levels and are associated with increased risk of developing MS syndrome (Lovrecic et al. 2008). The gene discussed is SERPINE1; the disease is multiple congenital anomalies-hypotonia-seizures syndrome 3.